Halozyme Therapeutics
HALO
$38.64
Share price
2.20%
Change (1 day)
10.27%
Change (1 year)
Categories
EPS for Halozyme Therapeutics (HALO)
EPS in 2023 (TTM): $1.74
According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $1.74. In 2022 the company made an earnings per share (EPS) of $1.48 a decrease over its 2021 EPS that were of $2.85.
EPS history for Halozyme Therapeutics from 2002 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.74 | 17.57% |
| 2022 | $1.48 | -48.07% |
| 2021 | $2.85 | 196.88% |
| 2020 | $0.96 | -292% |
| 2019 | -$0.50 | -9.09% |
| 2018 | -$0.55 | -237.5% |
| 2017 | $0.40 | -149.38% |
| 2016 | -$0.81 | 211.54% |
| 2015 | -$0.26 | -52.73% |
| 2014 | -$0.55 | -24.66% |
| 2013 | -$0.73 | 48.98% |
| 2012 | -$0.49 | 145% |
| 2011 | -$0.20 | -64.29% |
| 2010 | -$0.56 | -17.65% |
| 2009 | -$0.68 | 9.68% |
| 2008 | -$0.62 | 93.75% |
| 2007 | -$0.32 | 33.33% |
| 2006 | -$0.24 | -4% |
| 2005 | -$0.25 | -3.85% |
| 2004 | -$0.26 | -13.33% |
| 2003 | -$0.30 | 83.59% |
| 2002 | -$0.16 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 709.50% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | 6.90% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 212.03% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | 82.77% | 🇫🇷 France |
 Baxter BAX | $5.12 | 194.25% | 🇺🇸 USA |
 MannKind Corp MNKD | -$0.19 | -110.92% | 🇺🇸 USA |